1. Home
  2. JAGX vs SSKN Comparison

JAGX vs SSKN Comparison

Compare JAGX & SSKN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • JAGX
  • SSKN
  • Stock Information
  • Founded
  • JAGX 2013
  • SSKN 1989
  • Country
  • JAGX United States
  • SSKN United States
  • Employees
  • JAGX N/A
  • SSKN N/A
  • Industry
  • JAGX Biotechnology: Pharmaceutical Preparations
  • SSKN Medical/Dental Instruments
  • Sector
  • JAGX Health Care
  • SSKN Health Care
  • Exchange
  • JAGX Nasdaq
  • SSKN Nasdaq
  • Market Cap
  • JAGX 11.3M
  • SSKN 12.5M
  • IPO Year
  • JAGX N/A
  • SSKN 2005
  • Fundamental
  • Price
  • JAGX $0.86
  • SSKN $3.05
  • Analyst Decision
  • JAGX
  • SSKN
  • Analyst Count
  • JAGX 0
  • SSKN 0
  • Target Price
  • JAGX N/A
  • SSKN N/A
  • AVG Volume (30 Days)
  • JAGX 505.4K
  • SSKN 4.7K
  • Earning Date
  • JAGX 11-13-2024
  • SSKN 11-13-2024
  • Dividend Yield
  • JAGX N/A
  • SSKN N/A
  • EPS Growth
  • JAGX N/A
  • SSKN N/A
  • EPS
  • JAGX N/A
  • SSKN N/A
  • Revenue
  • JAGX $10,480,000.00
  • SSKN $32,674,999.00
  • Revenue This Year
  • JAGX $32.33
  • SSKN $0.94
  • Revenue Next Year
  • JAGX $43.63
  • SSKN $11.30
  • P/E Ratio
  • JAGX N/A
  • SSKN N/A
  • Revenue Growth
  • JAGX N/A
  • SSKN N/A
  • 52 Week Low
  • JAGX $0.84
  • SSKN $2.51
  • 52 Week High
  • JAGX $21.60
  • SSKN $6.50
  • Technical
  • Relative Strength Index (RSI)
  • JAGX 40.81
  • SSKN 55.69
  • Support Level
  • JAGX $0.84
  • SSKN $2.96
  • Resistance Level
  • JAGX $1.29
  • SSKN $3.15
  • Average True Range (ATR)
  • JAGX 0.09
  • SSKN 0.12
  • MACD
  • JAGX -0.01
  • SSKN 0.01
  • Stochastic Oscillator
  • JAGX 3.59
  • SSKN 79.31

About JAGX Jaguar Health Inc.

Jaguar Health Inc is a commercial-stage pharmaceuticals company focused on developing novel, plant-based, non-opioid, and sustainably derived prescription medicines for people and animals with GI distress, specifically chronic, debilitating diarrhea. Its product Mytesi is a novel, first-in-class anti-secretory agent which has a basic normalizing effect locally on the gut, and this mechanism of action has the potential to benefit multiple disorders. It has two reportable segments namely human health and animal health. The company generates the majority of its revenue from the Human Health segment.

About SSKN Strata Skin Sciences Inc.

Strata Skin Sciences Inc is a medical technology company engaged in developing and commercializing products for the treatment of dermatological disorders. Its primary products include the XTRAC excimer laser and VTRAC lamp systems utilized in the treatment of psoriasis, vitiligo and various other skin conditions. Its operating segment includes Dermatology Recurring Procedures which is the key revenue driver and Dermatology Procedures Equipment. The Dermatology Recurring Procedures segment derives its revenues from the usage of its equipment by dermatologists to perform XTRAC procedures. Its Dermatology Procedures Equipment segment generates revenues from the sale of equipment, such as lasers and lamp products. Geographically, it derives a majority of revenue from the United states.

Share on Social Networks: